IRVINE, CA -- (Marketwired) -- 09/04/13 -- AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on…
Continue ReadingTag: atheronova-inc
AtheroNova CEO Tom Gardner to Present at Rodman & Renshaw Conference Tuesday, September 13
Highlights of Mr. Gardner-s Presentation to Include Recently Announced Maxwell Biotech Group Agreement and MOA of…
Continue ReadingAtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug
Maxwell to Fund Clinical Trials, Become Equity Investor in AtheroNova, and License AHRO-001 for Russia
Continue Reading